NATCOPHARM

Natco Pharma, a midcap player in the pharmaceuticals and drugs industry, has recently experienced a notable decline in its stock performance. On February 13, 2025, the company's stock fell by 19.09%, underperforming the sector by 17.07%. This decline marks a challenging period for Natco Pharma, as it has faced consecutive losses over the past five days, resulting in a total drop of 23.64% during this timeframe. The stock opened significantly lower, with an initial loss of 18.96%, and reached an intraday low of Rs 986. High volatility characterized the trading day, with an intraday volatility rate of 48.07%. Additionally, Natco Pharma's stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.